Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial

IMPORTANCE: The NAVIGATE ESUS randomized clinical trial found that 15 mg of rivaroxaban per day does not reduce stroke compared with aspirin in patients with embolic stroke of undetermined source (ESUS); however, it substantially reduces stroke risk in patients with atrial fibrillation (AF). OBJECTI...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Neurol
Main Authors: Healey, Jeff S., Gladstone, David J., Swaminathan, Balakumar, Eckstein, Jens, Mundl, Hardi, Epstein, Andrew E., Haeusler, Karl Georg, Mikulik, Robert, Kasner, Scott E., Toni, Danilo, Arauz, Antonio, Ntaios, George, Hankey, Graeme J., Perera, Kanjana, Pagola, Jorge, Shuaib, Ashfaq, Lutsep, Helmi, Yang, Xiaomeng, Uchiyama, Shinichiro, Endres, Matthias, Coutts, Shelagh B., Karliński, Michal, Czlonkowska, Anna, Molina, Carlos A., Santo, Gustavo, Berkowitz, Scott D., Hart, Robert G., Connolly, Stuart J.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2019
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583060/
https://ncbi.nlm.nih.gov/pubmed/30958508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.0617
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker